As Johnson & Johnson (JNJ) Valuation Rose, Prentiss Smith & Co Has Increased Position by $336,720; Denali Advisors Holding in Garmin LTD (GRMN) Has Lifted by $2.93 Million as Market Value Declined

Johnson & Johnson (NYSE:JNJ) Logo

Denali Advisors Llc increased its stake in Garmin Ltd (GRMN) by 76.04% based on its latest 2018Q3 regulatory filing with the SEC. Denali Advisors Llc bought 41,900 shares as the company’s stock declined 4.56% with the market. The institutional investor held 97,000 shares of the industrial machinery and components company at the end of 2018Q3, valued at $6.80M, up from 55,100 at the end of the previous reported quarter. Denali Advisors Llc who had been investing in Garmin Ltd for a number of months, seems to be bullish on the $13.46B market cap company. The stock decreased 0.36% or $0.26 during the last trading session, reaching $71.29. About 325,391 shares traded. Garmin Ltd. (NASDAQ:GRMN) has risen 5.97% since February 13, 2018 and is uptrending. It has outperformed by 5.97% the S&P500. Some Historical GRMN News: 08/03/2018 – GARMIN – ANNOUNCED TACTIX CHARLIE, A GPS WEARABLE THAT COMBINES TACTICAL FUNCTIONALITY WITH NAVIGATION AND FITNESS TRAINING; 02/05/2018 – GARMIN 1Q ADJ EPS 68C, EST. 56C; 13/03/2018 – Nordea: Nordea rolls out payment solution for Fitbit, Garmin smartwatches; 15/03/2018 – Garmin® unveils Ultra High-Definition scanning sonar; 08/03/2018 – Garmin® introduces the tactix® Charlie, a specialized tactical GPS watch with wrist-based heart rate; 02/05/2018 – Garmin Sees FY18 Adj EPS $3.05; 18/04/2018 – Garmin® introduces the Edge® 520 Plus — a GPS cycling computer with advanced navigation and connected features; 04/05/2018 – Garmin Conference Call Scheduled By Aliya Capital for May. 11; 02/05/2018 – GARMIN SEES FY ADJ EPS $3.05, EST. $3.08; 06/03/2018 – GARMIN INTERNATIONAL – FLIGHT PLANS MAY BE TRANSFERRED FROM FLTPLAN GO TO GARMIN PILOT APPLICATION FOR IOS AND ANDROID USERS

Prentiss Smith & Co Inc increased its stake in Johnson & Johnson (JNJ) by 3.55% based on its latest 2018Q3 regulatory filing with the SEC. Prentiss Smith & Co Inc bought 2,440 shares as the company’s stock rose 5.87% while stock markets declined. The institutional investor held 71,242 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $9.84 million, up from 68,802 at the end of the previous reported quarter. Prentiss Smith & Co Inc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $359.31B market cap company. The stock decreased 0.14% or $0.19 during the last trading session, reaching $133.97. About 3.64M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 3.75% since February 13, 2018 and is uptrending. It has outperformed by 3.75% the S&P500. Some Historical JNJ News: 24/04/2018 – Johnson & Johnson to Participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference; 21/03/2018 – J.J. Redick Might Be the N.B.A.’s Most Meticulous Player; 17/04/2018 – Johnson & Johnson Backs 2018 View of Adj EPS $8.00-Adj EPS $8.20; 02/04/2018 – Fidelity Advisor New Insights Adds GE, Exits J&J; 23/03/2018 – GSK’s two-drug HIV regimen wins European panel approval; 29/05/2018 – Genmab takes a hit after J&J sounds retreat on cancer combos, as patient deaths force researches to scrap trials $JNJ; 09/04/2018 – J&J Faces Talc Penalty in Continuing Legal Case (Corret); 02/04/2018 – Fidelity Contrafund Adds Dr Pepper Snapple, Exits J&J; 05/04/2018 – Johnson & Johnson Institute Adds Innovative Analytics-Based Learning Platform to Help Surgeons Improve Technical Skills and Clinical Outcomes Across a Range of Specialties; 21/05/2018 – Ahold Delhaize USA Announces Peapod Digital Labs and Names JJ Fleeman President and Chief eCommerce Officer

Among 16 analysts covering Garmin Ltd. (NASDAQ:GRMN), 3 have Buy rating, 4 Sell and 9 Hold. Therefore 19% are positive. Garmin Ltd. had 35 analyst reports since July 30, 2015 according to SRatingsIntel. The stock of Garmin Ltd. (NASDAQ:GRMN) has “Buy” rating given on Monday, March 12 by Tigress Financial. Robert W. Baird maintained the shares of GRMN in report on Thursday, February 22 with “Neutral” rating. The stock of Garmin Ltd. (NASDAQ:GRMN) earned “Neutral” rating by Citigroup on Thursday, October 29. The stock has “Mkt Perform” rating by Raymond James on Monday, August 22. The company was downgraded on Monday, May 7 by Credit Suisse. The rating was downgraded by JP Morgan on Thursday, February 18 to “Underweight”. The rating was maintained by Tigress Financial on Friday, December 15 with “Buy”. JP Morgan downgraded Garmin Ltd. (NASDAQ:GRMN) on Thursday, July 30 to “Underweight” rating. Longbow upgraded the stock to “Buy” rating in Wednesday, July 19 report. DA Davidson maintained Garmin Ltd. (NASDAQ:GRMN) on Friday, September 11 with “Neutral” rating.

More notable recent Garmin Ltd. (NASDAQ:GRMN) news were published by: Bizjournals.com which released: “How a Garmin wearable helped nab a British mob hitman – Kansas City Business Journal” on January 18, 2019, also Nasdaq.com with their article: “Garmin Ltd. (GRMN) Ex-Dividend Date Scheduled for September 13, 2018 – Nasdaq” published on September 12, 2018, Nasdaq.com published: “That’s Odd: Bearish GRMN Analysts See 11.71% Upside – Nasdaq” on December 18, 2018. More interesting news about Garmin Ltd. (NASDAQ:GRMN) were released by: Nasdaq.com and their article: “PHG or GRMN: Which Is the Better Value Stock Right Now? – Nasdaq” published on February 06, 2019 as well as Benzinga.com‘s news article titled: “Apple Watches Could Be Covered by Insurance, In Boost To Wearables Sector (NASDAQ:AAPL) – Benzinga” with publication date: January 17, 2019.

Denali Advisors Llc, which manages about $357.49 million and $680.59 million US Long portfolio, decreased its stake in M&T Bank Corp. (NYSE:MTB) by 34,500 shares to 7,300 shares, valued at $1.20M in 2018Q3, according to the filing. It also reduced its holding in Rpc Inc. (NYSE:RES) by 29,800 shares in the quarter, leaving it with 28,300 shares, and cut its stake in Avnet Inc. (NYSE:AVT).

Investors sentiment increased to 1.4 in 2018 Q3. Its up 0.09, from 1.31 in 2018Q2. It is positive, as 29 investors sold GRMN shares while 107 reduced holdings. 63 funds opened positions while 127 raised stakes. 78.02 million shares or 3.30% more from 75.52 million shares in 2018Q2 were reported. Retirement System Of Alabama has 0.02% invested in Garmin Ltd. (NASDAQ:GRMN). Bp Public Limited Com invested in 0.03% or 15,000 shares. Segment Wealth Management accumulated 60,489 shares. Comm Bankshares, Missouri-based fund reported 244,346 shares. Bessemer Group has invested 0% in Garmin Ltd. (NASDAQ:GRMN). Smithfield Trust stated it has 0% of its portfolio in Garmin Ltd. (NASDAQ:GRMN). National Bank Of Nova Scotia reported 0% in Garmin Ltd. (NASDAQ:GRMN). Moreover, Baker Avenue Asset LP has 0.05% invested in Garmin Ltd. (NASDAQ:GRMN) for 9,112 shares. Segall Bryant And Hamill Lc accumulated 2,900 shares. Sector Pension Board has 5,705 shares for 0% of their portfolio. Royal London Asset Mgmt Ltd reported 0% stake. Rhumbline Advisers owns 0.03% invested in Garmin Ltd. (NASDAQ:GRMN) for 198,643 shares. Barclays Public Ltd Com accumulated 359,274 shares. Amer Century stated it has 0.03% in Garmin Ltd. (NASDAQ:GRMN). Da Davidson & holds 0.01% of its portfolio in Garmin Ltd. (NASDAQ:GRMN) for 4,589 shares.

Since August 15, 2018, it had 0 insider buys, and 15 insider sales for $259.94 million activity. PEMBLE CLIFTON A also sold $1.09M worth of Garmin Ltd. (NASDAQ:GRMN) shares.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Investorplace.com which released: “Should You Load Up on JNJ Stock Before Earnings? – Investorplace.com” on January 18, 2019, also Zacks.com with their article: “Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy? – Zacks.com” published on January 15, 2019, Benzinga.com published: “Johnson & Johnson Wins FDA Panel Backing For Nasal Spray Depression Drug; PDUFA Date Awaits (NYSE:JNJ) – Benzinga” on February 13, 2019. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Benzinga.com and their article: “Analysts Stand By Johnson & Johnson Despite Earnings Pullback (NYSE:JNJ) – Benzinga” published on January 23, 2019 as well as Investorplace.com‘s news article titled: “5 Top Stock Trades for Wednesday: JNJ, CMG, MO, EBAY – Investorplace.com” with publication date: January 22, 2019.

Since August 27, 2018, it had 3 buys, and 8 selling transactions for $79.44 million activity. 29,000 Johnson & Johnson (NYSE:JNJ) shares with value of $3.91 million were sold by Sneed Michael E. 166,695 shares valued at $24.41 million were sold by Fasolo Peter on Monday, December 3. $1.08 million worth of Johnson & Johnson (NYSE:JNJ) was sold by Kapusta Ronald A. $268,731 worth of Johnson & Johnson (NYSE:JNJ) was bought by PRINCE CHARLES on Friday, December 14. $5.77M worth of Johnson & Johnson (NYSE:JNJ) was sold by Duato Joaquin. 264,465 shares were sold by Gorsky Alex, worth $38.60 million on Friday, November 16.

Among 25 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 4 Sell and 9 Hold. Therefore 48% are positive. Johnson & Johnson had 111 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Johnson & Johnson (NYSE:JNJ) has “Neutral” rating given on Monday, March 14 by Goldman Sachs. The rating was maintained by Jefferies with “Buy” on Tuesday, January 16. The rating was maintained by Argus Research with “Buy” on Wednesday, April 20. Cowen & Co maintained it with “Buy” rating and $14300 target in Tuesday, June 13 report. The stock of Johnson & Johnson (NYSE:JNJ) earned “Hold” rating by Societe Generale on Wednesday, April 6. The firm earned “Buy” rating on Monday, July 10 by RBC Capital Markets. On Wednesday, October 17 the stock rating was maintained by Raymond James with “Outperform”. On Wednesday, April 18 the stock rating was maintained by Wells Fargo with “Buy”. The rating was downgraded by Goldman Sachs to “Sell” on Wednesday, September 20. Piper Jaffray maintained it with “Hold” rating and $120.0 target in Monday, October 2 report.

Investors sentiment increased to 1.05 in Q3 2018. Its up 0.08, from 0.97 in 2018Q2. It is positive, as 43 investors sold JNJ shares while 748 reduced holdings. 115 funds opened positions while 719 raised stakes. 1.70 billion shares or 7.91% less from 1.84 billion shares in 2018Q2 were reported. Ashford Capital Mgmt holds 3,250 shares. Mutual Federation Of Agricultural Cooperatives owns 31,900 shares for 0.06% of their portfolio. First Dallas Securities has invested 2.38% in Johnson & Johnson (NYSE:JNJ). Shayne Limited has invested 0.17% in Johnson & Johnson (NYSE:JNJ). Eubel Brady Suttman Asset Mngmt owns 124,054 shares for 5.07% of their portfolio. Retirement Of Alabama reported 1.86 million shares. Hutchinson Ca reported 0.43% stake. Diamond Hill Management Incorporated holds 2,037 shares. Bkd Wealth Advisors Ltd Liability Co accumulated 0.49% or 40,457 shares. Wesbanco Commercial Bank stated it has 257,130 shares or 1.75% of all its holdings. Hayek Kallen Inv Mgmt reported 39,391 shares. Nelson Van Denburg And Campbell Wealth Group Ltd Company invested in 0.64% or 21,906 shares. Fil Ltd holds 0.94% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 4.58 million shares. 9,862 were reported by Fund Evaluation Grp Ltd Llc. Asset Inc invested in 0.58% or 258,067 shares.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart